Michael Guggemos
Direktor/Vorstandsmitglied bei Regierungskommission Deutscher Corporate Governance Kodex
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Sebastian Dullien | M | - |
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | 5 Jahre |
Thomas Rödder | M | - |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | - |
Daniel Hay | M | 45 |
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | 4 Jahre |
Bettina Kohlrausch | M | - |
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | 4 Jahre |
Aline Zucco | M | - |
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | 4 Jahre |
Sebastian Watzka | M | - |
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | 7 Jahre |
Anna Maria Braun | F | - |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | 5 Jahre |
Nils Werner | M | - |
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | 7 Jahre |
Jan Paul Giertz | M | - |
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | 9 Jahre |
Maxi Leuchters | F | 30 |
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | 5 Jahre |
Wulf von Schimmelmann | M | 77 |
Regierungskommission Deutscher Corporate Governance Kodex
Regierungskommission Deutscher Corporate Governance Kodex General GovernmentGovernment Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany. | 8 Jahre |
Olaf Elixmann | M | - |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | - |
Malte Lübker | M | - |
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | 7 Jahre |
Dorothee Spannagel | M | - |
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | 10 Jahre |
Lars Elmenthaler | M | - |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | - |
Karl Friedrich Braun | M | - |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | - |
Friederike Braun-Lüdicke | M | - |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | 3 Jahre |
Tobias Polloczek | M | - |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | - |
Thorsten Nöll | M | - |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | - |
Manfred Gertz | M | - |
Regierungskommission Deutscher Corporate Governance Kodex
Regierungskommission Deutscher Corporate Governance Kodex General GovernmentGovernment Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany. | - |
Yvonne Lott | M | - |
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | 8 Jahre |
Sabine Süpke | F | - |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | - |
Klaus-Peter Naumann | M | - |
Regierungskommission Deutscher Corporate Governance Kodex
Regierungskommission Deutscher Corporate Governance Kodex General GovernmentGovernment Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany. | - |
Margarete Haase | M | 71 |
Regierungskommission Deutscher Corporate Governance Kodex
Regierungskommission Deutscher Corporate Governance Kodex General GovernmentGovernment Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany. | 8 Jahre |
Daniela Weber-Rey | F | 66 |
Regierungskommission Deutscher Corporate Governance Kodex
Regierungskommission Deutscher Corporate Governance Kodex General GovernmentGovernment Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany. | 16 Jahre |
Frank Heinricht | M | 62 |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | - |
Joachim Faber | M | 74 |
Regierungskommission Deutscher Corporate Governance Kodex
Regierungskommission Deutscher Corporate Governance Kodex General GovernmentGovernment Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany. | 11 Jahre |
Stefan Schulte | M | 64 |
Regierungskommission Deutscher Corporate Governance Kodex
Regierungskommission Deutscher Corporate Governance Kodex General GovernmentGovernment Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany. | 12 Jahre |
Michael Mertin | M | 58 |
Regierungskommission Deutscher Corporate Governance Kodex
Regierungskommission Deutscher Corporate Governance Kodex General GovernmentGovernment Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany. | 11 Jahre |
Claudia Kruse | F | - |
Regierungskommission Deutscher Corporate Governance Kodex
Regierungskommission Deutscher Corporate Governance Kodex General GovernmentGovernment Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany. | 8 Jahre |
Rolf Nonnenmacher | M | 70 |
Regierungskommission Deutscher Corporate Governance Kodex
Regierungskommission Deutscher Corporate Governance Kodex General GovernmentGovernment Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany. | 8 Jahre |
Theodor Baums | M | - |
Regierungskommission Deutscher Corporate Governance Kodex
Regierungskommission Deutscher Corporate Governance Kodex General GovernmentGovernment Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany. | 15 Jahre |
Marc Tüngler | M | 56 |
Regierungskommission Deutscher Corporate Governance Kodex
Regierungskommission Deutscher Corporate Governance Kodex General GovernmentGovernment Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany. | 9 Jahre |
Jens Wilhelm | M | 58 |
Regierungskommission Deutscher Corporate Governance Kodex
Regierungskommission Deutscher Corporate Governance Kodex General GovernmentGovernment Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany. | 8 Jahre |
Kathrin Dahnke | F | 64 |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | - |
Thomas Kremer | M | 67 |
Regierungskommission Deutscher Corporate Governance Kodex
Regierungskommission Deutscher Corporate Governance Kodex General GovernmentGovernment Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany. | 11 Jahre |
Christine Maria Bortenlänger | M | 57 |
Regierungskommission Deutscher Corporate Governance Kodex
Regierungskommission Deutscher Corporate Governance Kodex General GovernmentGovernment Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany. | - |
Alexandra Friedrich | F | - |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | - |
Mike Schwarz | M | - |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | - |
Markus W. Büchler | M | - |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | - |
Oliver Schnell | M | - |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | - |
Thomas Theobald | M | 43 |
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | 10 Jahre |
Maria Schwarz | F | - |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Gustav A. Horn | M | 69 |
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | 14 Jahre |
Fabian Lindner | M | - |
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | 18 Jahre |
Kai Daniel Schmid | M | - |
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | - |
Ansgar Rannenberg | M | - |
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Deutschland | 47 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Michael Guggemos
- Persönliches Netzwerk